Compounds > adamantane
Page last updated: 2024-08-21

adamantane and Brain Neoplasms

adamantane has been researched along with Brain Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Defant, A; Mancini, I; Pancher, M; Quattrone, A; Rosatti, EF; Sidarovich, V; Sighel, D; Vigna, J1
De, L; Yong, Z; Yuan, T1
Drummond, KJ; Kan, LK; Monif, M; O'Brien, TJ; Seneviratne, S; Williams, DA1
Avramis, IA; Avramis, VI; Christodoulopoulos, G; Gonzalez-Gomez, I; Laug, WE; McNamara, G; Sausville, EA; Suzuki, A1

Other Studies

4 other study(ies) available for adamantane and Brain Neoplasms

ArticleYear
Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth.
    Marine drugs, 2023, Mar-17, Volume: 21, Issue:3

    Topics: Adamantane; Arsenic Trioxide; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Stem Cells

2023
ST1926 inhibits glioma progression through regulating mitochondrial complex II.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 128

    Topics: Adamantane; Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cinnamates; Disease Progression; Electron Transport Complex II; Energy Metabolism; Enzyme Inhibitors; Glioma; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays

2020
P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
    Purinergic signalling, 2020, Volume: 16, Issue:3

    Topics: Adamantane; Aminoquinolines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Microglia; Microscopy, Confocal; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Tumor Microenvironment

2020
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:6

    Topics: Adamantane; Animals; Blotting, Western; Brain Neoplasms; Caspase 3; Caspases; DNA, Neoplasm; Drug Resistance, Neoplasm; Endothelial Growth Factors; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Female; Fusion Proteins, bcr-abl; Glioblastoma; Humans; Hydroquinones; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Leukemia, T-Cell; Lymphokines; Mice; Mice, Nude; Myosin Heavy Chains; Neoplasm Transplantation; Nonmuscle Myosin Type IIB; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors

2002